PP_1170x120_10-25-21

Xlear

Xlear submits COVID-19 pre-EAU request with FDA regarding use of Xlear Nasal Spray to help in combating SARS-CoV-2

Xlear submits COVID-19 pre-EAU request with FDA regarding use of Xlear Nasal Spray to help in combating SARS-CoV-2

WASHINGTON — Xlear is filing a Pre-Emergency Use Authorization (Pre-EUA) Request with the U.S. Food and Drug Administration (FDA). The Pre-EUA is a first step in seeking authorization of Xlear Nasal Spray as a new hygiene tool to help in combat the SARS-CoV-2 virus, the virus that causes COVID-19. Xlear’s Pre-EUA Request is based on

Xlear highlights new research that shows that Xylitol blocks adhesion of SARS CoV-2

Xlear highlights new research that shows that Xylitol blocks adhesion of SARS CoV-2

AMERICAN FORK, Utah — The latest results from the University of Tennessee confirm that xylitol (the active ingredient in Xlear Nasal Spray), has a potent ability to block viral adhesion of the Sars-Cov-2, inactivating more than 99.9% of SARS-CoV-2, the virus that causes COVID-19. This new report comes out to support the report from Utah

Xlear nasal products hit shelves at CVS, Target

Xlear nasal products hit shelves at CVS, Target

SALT LAKE CITY — Xlear Inc. has landed retail distribution for its xylitol-based nasal sinus care products at CVS Pharmacy and Target stores nationwide. Xlear said Wednesday that products now available at Target include the 1.5-oz. Xlear Nasal Spray, Neti Pot Kit, Sinus Spray Kit and Solution Packets. CVS is stocking in its stores the

Adheris Health